DEPLOY

Partnership

B-TEMIA x Nasdaq

technology · Active · just announced


Machine-readable surfaces

dc8f1405-39b9-4c18-9156-da7727f2885e
Type
technology
Status
Activejust announced

Who’s involved

B-TEMIAco developer

Canadian bio-robotics company developing Dermoskeleton™ technology for human mobility augmentation. Its flagship product [Keeogo](/models/btemia-keeogo) is a powered lower-limb exoskeleton that provides motorized knee assistance for stroke patients and individuals with mobility impairments in rehabilitation settings. B-TEMIA received FDA 510(k) clearance for Keeogo in September 2020 and was acquired by Wistron Medical Tech Holding Company in 2025 through a court-approved stalking horse agreement following insolvency proceedings

HQSaint-Augustin-de-Desmaures, Quebec, Canadawww.b-temia.com2 partnerships

Most-frequent partners

Nasdaqco developer

Nasdaq, Inc. (NASDAQ: NDAQ) is a [Global](/companies/global-ai) technology and financial services company headquartered in New York City. It operates the Nasdaq stock exchange and provides trading, clearing, exchange technology, and market data services worldwide.

HQNew York, New York, USAnasdaq.com1 partnerships

Most-frequent partners

Related partnerships

Other partnerships of B-TEMIA

Recent partnerships of the same kind

Sources (1)

  1. https://www.nasdaq.com/articles/b-temia-lists-on-nasdaq

Deploy Watch

Track this partnership.

We notify you when the status changes against primary-source evidence, expansion is verified, or the partnership is terminated.